Ascendis Pharma A/S
(ASND)
undefined
undefined%
At close: undefined
129.87
-0.29%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -481.45M | -583.19M | -383.58M | -418.95M | -218.02M | -130.10M | -123.90M | -68.50M | -32.92M | -9.66M | 4.08M | 1.25M |
| Depreciation & Amortization | 18.91M | 17.96M | 15.39M | 9.45M | 6.69M | 880.00K | 734.00K | 677.00K | 558.00K | 504.00K | 405.00K | 425.00K |
| Stock-Based Compensation | 66.66M | 64.18M | 66.83M | 53.17M | 37.49M | 19.65M | 9.71M | 7.32M | 1.71M | 1.27M | 671.00K | 125.00K |
| Other Working Capital | 7.09M | 2.86M | -7.33M | -964.00K | 4.07M | -6.74M | -5.83M | -1.42M | -8.29M | -10.44M | -3.48M | 2.01M |
| Other Non-Cash Items | 21.00M | 18.60M | -67.01M | 85.97M | -5.93M | -30.55M | 13.81M | -3.51M | -7.50M | -2.44M | 4.00K | -35.00K |
| Deferred Income Tax | 7.30M | 5.38M | -367.00K | -219.00K | -234.00K | -394.00K | -477.00K | -227.00K | -652.00K | -682.00K | 626.00K | 35.00K |
| Change in Working Capital | -99.79M | -18.62M | -48.91M | -964.00K | 4.07M | 1.71M | 5.02M | 4.07M | -4.66M | -7.40M | 525.00K | -2.45M |
| Operating Cash Flow | -467.36M | -495.70M | -417.65M | -271.55M | -175.94M | -138.80M | -95.10M | -60.18M | -43.47M | -18.40M | 6.31M | -652.00K |
| Capital Expenditures | -2.44M | -14.49M | -24.23M | -21.55M | -5.16M | -2.65M | -941.00K | -672.00K | -1.04M | -405.00K | -1.20M | -291.00K |
| Acquisitions | 49.95K | 9.36M | -10.19M | 1.69M | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | -213.84M | -226.04M | -537.75M | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | 288.87M | 280.53M | 149.88M | 263.05M | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | 1.05K | 171.73K | -86.88M | 3.36M | - | - | - | - | - | - | - | - |
| Investing Cash Flow | 286.47M | 61.73M | -110.58M | -291.20M | -5.16M | -2.65M | -941.00K | -672.00K | -1.04M | -405.00K | -1.20M | -291.00K |
| Debt Repayment | 125.82M | 496.93M | -6.43M | -4.77M | -4.04M | - | - | - | - | - | -220.00K | -205.00K |
| Common Stock Repurchased | -1.81M | -105.31M | -21.61M | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 8.47M | 5.15M | 11.54M | 26.88M | 17.38M | -13.12M | -8.39M | -8.50M | -8.40M | -189.00K | - | - |
| Financial Cash Flow | 134.29M | 396.77M | 351.39M | 602.65M | 493.59M | 203.27M | 124.72M | 117.46M | 105.74M | 47.91M | -220.00K | -205.00K |
| Net Cash Flow | -52.60M | -1.50M | -138.25M | -13.59M | 320.24M | 82.51M | 15.02M | 60.68M | 69.48M | 30.74M | 4.89M | -1.15M |
| Free Cash Flow | -469.80M | -510.19M | -441.88M | -293.10M | -181.09M | -141.45M | -96.04M | -60.85M | -44.51M | -18.81M | 5.12M | -943.00K |